期刊文献+

双向凝胶电泳联合MALDI-TOF/TOF MS技术探寻狼疮性肾炎的血清标志物

Exploring Serum Protein Biomarkers of Lupus Nephritis by Using Two-Dimensional Gel Electrophoresis Combined with Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry
下载PDF
导出
摘要 目的:通过双向凝胶电泳与基质辅助激光解吸电离串联飞行时间质谱(MALDI-TOF/TOF MS)技术初步探寻狼疮性肾炎(LN)患者潜在的血清分子标志物,为阐明LN的发病机制奠定基础。方法:将40例LN患者分为活动组和缓解组,每组20例;另选择IgA肾病患者和健康志愿者各20例,分别作为IgAN组和健康对照组。采用双向凝胶电泳技术分离血清蛋白质,并采用MALDI-TOF/TOF MS鉴定差异表达的蛋白质。结果:共发现50个差异表达蛋白质。与健康对照组相比,LN活动组和LN缓解组共发现23个差异表达的蛋白质,上调8个、下调15个;与IgAN组相比,LN活动组和LN缓解组共发现18个差异表达的蛋白质,上调13个,下调5个;与LN缓解组相比,LN活动组表达上调和下调的蛋白质分别为4个和5个。在鉴定出的50个差异表达蛋白中,血清淀粉样蛋白A(SAA)在LN活动组中的表达高于其他组,complement component C4A在LN活动组中的表达低于其他组;chain B(solution structure of double super helix model)在LN缓解组的表达高于其他组;与健康对照组相比,vitamin D-binding protein isoform1 precursor、chain A(crystal structure of uncomplexed vitamin D-binding protein)和chain B(a covalent dimer of transthyretin that affects the amyloid Pathway)等在LN活动组和LN缓解组的表达均上调,而vitronectin precursor、ficolin-2isoform a precursor和chain A(crystal structure of the catalytic domain of human complement C1s protease)则相反;与IgAN组相比,lipoprotein CIII和vitronectin precursor在LN活动组和LN缓解组的表达均上调。结论:双向凝胶电泳与MALDI-TOF/TOF MS联用技术有效实现了对LN患者血清差异表达蛋白质的筛选与鉴定。这些差异表达的蛋白质可作为生物标志物用于LN的无创性诊断和评估,对这些蛋白质的进一步研究将有助于更好地了解LN的发病机制。 Objective: To explore the potential serum biomarkers of patients with lupus nephritis(LN) by using twcdimensional electrophoresis combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry(MALDI-TOF/TOF MS), so as to lay the foundation for illuminating pathogenesis. Methods: A total of 40 LN patients were divided into two groups, the active LN group and the inactive LN group, with 20 in each. In addition, 20 IgA nephritis patients and 20 healthy volunteers were enrolled as IgAN group and healthy control group. Two-dimensional gel eiectrophoresis was used to separate and analyze the serum proteins, and MALDI-TOF/TOF MS was applied to the identification of the differentially expressed pro teins. Results: A total of fifty differentially expressed proteins were identified. Compared with that in healthy control group, 23 differentially expressed proteins were discovered in active LN group and inactive LN group, among which, 8 proteins were up-regulated and 15 proteins were down-regulated. And 18 differentially expressed proteins, compared with IgA nephritis group, were found in active LN group and inactive LN group, including 13 up-regulated proteins and 5 down-regulated proteins. Fur- thermore, the number of upregulated and down-regulated proteins in active LN group, compared with those in inactive LN group, were 4 and 5, respectively. Among the 50 identified differentially expressed proteins, the expression of serum amyloid protein A( SAA ) in active LN group was higher than that in the other groups while the expression of complement component CAA in active LN group was lower than that in the other groups. And the expression of chain B (solution structure of double super helix model) in the inactive LN group was higher than that in the other groups. Compared with that in healthy control group, the expression of vitamin D-binding protein isoform 1 precursor, chain A(crystal structure of uncomplexed vitamin D- binding protein) and chain B (a covalent dimer of transthyretin that affects the amyloid pathway) was up-regulated in both ac- tive LN group and inactive LN group, while the expression of the vitronectin precursor, ficolin-2 isoform a precursor and chain A (crystal structure of the catalytic domain of human complement Cls protease) was down regulated. Compared with that in IgA nephritis group, the expression of lipoprotein CIII and vitronectin precursor was up-regulated in both active LN group and inactive LN group. Conclusions: Combination of two-dimensional gel electrophoresis and MALDI-TOF/TOF MS is effective for screening and identification of differentially expressed proteins in serum from LN patients. These differentially expressed pro- teins could be used as biomarkers for noninvasive diagnosis and evaluation of LN. Further study on these proteins would be conducive to understanding the pathogenesis of LN.
出处 《中国临床医学》 2015年第4期459-464,共6页 Chinese Journal of Clinical Medicine
基金 上海市科委基础研究重点项目(编号:08JC1404300)
关键词 系统性红斑狼疮 狼疮性肾炎 蛋白质组学 质谱 生物标志物 Systemic lupus erythematosus Lupus nephritis Proteomics Mass spectrometry Biomarkers
  • 相关文献

参考文献7

  • 1Zhang X, Jin M, Wu H, et al. Biomarkers of lupus nephritis determined by serial urine proteomics[J]. Kidney Int, 2(108, 74(6) .. 799-807.
  • 2胡成效,戴勇,刘建军,何建凡,吕天羽.系统性红斑狼疮患者外周血单个核细胞蛋白质组学研究[J].中华风湿病学杂志,2009,13(11):779-782. 被引量:2
  • 3Tan EM, Cohen AS, Fries JF, et al. The 1982 revised erite ria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1982, 25(11):1271-1277.
  • 4Gladman DD, Ibanez D, Urowitz MB. Systemic lupus ery- thematosus disease activity index 2000[J]. J Rheumatol, 2002, 29(2) :288-291.
  • 5王鸿利,主编.实验诊断学[M].北京:人民卫生出版社,2006.431.
  • 6Kim YR, Hikima J, Jang HB, et al. Identification and deter ruination of antigenic proteins of Korean ranavirus-1 (KRV 1 ) using MALDI-TOF/TOF MS analysis[J]. Comp Immunol Microbiol Infect Dis, 2011, 34(3):237-245.
  • 7Marsching C, Eckhardt M, Grone HJ, et al. Imaging of eomplex sulfatides SM3 and SBla in mouse kidney using MALDI-TOF/TOF mass spectrometry [ J ]. Anal Bioanal Chem, 2011, 401 ( 1 ) : 53 64.

二级参考文献15

  • 1Silvestris F, Grinello D, Tucci M, et al. Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/APO2-I) in active lupus. Lupus, 2003, 12: 8-14.
  • 2Pittoni V, Valesini G. The clearance of apoptotic cells: replications for autoimmunity. Autoimmun Rev, 2002, 1: 154- 161.
  • 3Mariana J, Kaplan, Emily E, et al. The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. J Immunol, 2002, 169: 6020-6022.
  • 4Gaffney PM, Ortmann WA, Selby SA, et al. Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analysis of 187 sib-pair families. Am J Hum Genet, 2000, 66: 547-556.
  • 5Dotzlaw H, Sehulz M, Eggert M, et al. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochem Biophys Acta, 2004, 1696: 121-129.
  • 6Pavon E J, Munoz P, Lario A, et al. Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin 2 polypeptide chains over the 1 isoforms. Proteomics, 2006, 6(Suppl 1 ): 282-292.
  • 7Mestecky J, Moro I, Moldoveanu Z, et al. Immunoglobulin J chain: an early differentiation marker of human B cells. Ann N Y Acad Sci, 1997, 5: 111-113.
  • 8Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin Al in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest, 1980, 66: 1432-1436.
  • 9Brun JG, Haga HI, Bφe E, et al. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity. J Rheumatol, 1992, 19: 859-862.
  • 10Hammer HB, Odegard S, Fagerhol MK, et al. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis, 2007, 66: 1093-1097.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部